According to Fortress Biotech 's latest financial reports the company's current EPS (TTM) is -$10.79. In 2022 the company made an earnings per share (EPS) of -$10.64 a decrease over its 2021 EPS that were of -$6.53.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$10.79 | 1.41% |
2022 | -$10.64 | 62.94% |
2021 | -$6.53 | -25.46% |
2020 | -$8.76 | 30.36% |
2019 | -$6.72 | -67.97% |
2018 | -$20.98 | -1.13% |
2017 | -$21.22 | 45.94% |
2016 | -$14.54 | 1.96% |
2015 | -$14.26 | 66.78% |
2014 | -$8.55 | -42.31% |
2013 | -$14.82 | -23.41% |
2012 | -$19.35 | -81.18% |
2011 | -$102.81 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Veracyte VCYT | -$0.40 | -96.29% | ๐บ๐ธ USA |
Advaxis ADXS | -$5.97 | -44.67% | ๐บ๐ธ USA |
Dynavax Technologies
DVAX | $0.87 | -108.06% | ๐บ๐ธ USA |